Loading...
Treatment of Advanced or Recurrent Endometrial Carcinoma with Doxorubicin in Patients Progressing after Paclitaxel/Carboplatin: Memorial Sloan-Kettering Cancer Center (MSKCC) Experience from 1995-2009
OBJECTIVE: Long-term survival for patients with advanced endometrial carcinoma is poor, and limited options exist for the management of recurrent disease. Our goal was to investigate the activity of doxorubicin in the second-line setting in patients who progressed after paclitaxel/carboplatin adjuva...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3694716/ https://ncbi.nlm.nih.gov/pubmed/23598889 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/IGC.0b013e3182915c20 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|